YHLO

2022-02-23

Summary:Shenzhen YHLO and its Hong Kong partner, Hong Kong C-Mer (C-Mer Eye Care Holdings Limited), announced that they donated once again to the Hong Kong society on February 22, after the donation of 300,000 YHLO COVID-19 Rapid Antigen Tests to the Hong Kong on February 16.





Shenzhen YHLO and its Hong Kong partner, Hong Kong C-Mer (C-Mer Eye Care Holdings Limited), announced that they donated once again to the Hong Kong society on February 22, after the donation of 300,000 YHLO COVID-19 Rapid Antigen Tests to the Hong Kong on February 16. The total number of the donations increased to 600,000 tests. YHLO and C-Mer are joining hands to help Hong Kong citizens to fight against COVID-19.

Previous: Officially Established, YHLO Japan R&D Center Set sail

Next: YHLO And C-Mer Donated 300,000 COVID-19 Antigen Tests To Hong Kong

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +